Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Steven J, Kussick"'
Publikováno v:
Cytometry Part B: Clinical Cytometry. 90:493-498
Background CD200 is a membrane bound glycoprotein that is expressed by a variety of normal tissues and hematopoietic malignancies. Flow cytometric analysis of CD200 expression has utility in the evaluation of mature B-cell neoplasms, myeloma, and acu
Publikováno v:
Journal of Hematopathology. 8:37-41
A 76-year-old Asian man with a 6-month history of intractable watery diarrhea proceeded to colonoscopic examination that revealed diffusely dull-appearing colonic mucosa with focal areas of superficial ulceration. Mucosal biopsies demonstrated a neop
Autor:
Steven J. Kussick, Jaimie G. Halley, Daniel D. Rhoads, Michael Keeney, Kumudini U. Mehta, Michael A. Linden, William J. Karlon, M. Qasim Ansari, David M. Dorfman
Publikováno v:
Archives of Pathology & Laboratory Medicine. 139:1276-1280
Context Flow cytometry is often applied to minimal residual disease (MRD) testing in hematolymphoid neoplasia. Because flow-based MRD tests are developed in the laboratory, testing methodologies and lower levels of detection (LODs) are laboratory dep
Autor:
John Anastasi, Daniel A. Arber, Dong Chen, Kudakwashe Chikwava, John Kim Choi, James R. Cook, Yuri Fedoriw, Falko Fend, Judith A. Ferry, William G. Finn, Juehua Gao, Tracy I. George, Robert Paul Hasserjian, Rong He, James D. Hoyer, Eric D. Hsi, Rebecca L. King, Kandice Kottke-Marchant, Paul J. Kurtin, Steven J. Kussick, Pei Lin, William R. Macon, Sara A. Monaghan, Megan O. Nakashima, Phuong L. Nguyen, Robert S. Ohgami, Jennifer L. Oliveira, Dennis P. O'Malley, Jennifer Lee Picarsic, Leticia Quintanilla-Martinez, Heesun J. Rogers, Jonathan W. Said, Graham W. Slack, Lauren Smith, Beenu Thakral, David S. Viswanatha, Sa A. Wang, James M. Ziai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0def7f22a8fd7bacfa20293ba5dbfb9a
https://doi.org/10.1016/b978-0-323-47913-4.00031-8
https://doi.org/10.1016/b978-0-323-47913-4.00031-8
Autor:
Antonios Papanicolau-Sengos, Natalie Vandeven, Paul Nghiem, Kinsey A. McCormick, Veena Shankaran, Faith Miller, Maria Westerhoff, Astrid Blom, Jason E. Love, Kimberly Thompson, Claire E. Murphy, Steven J. Kussick, Mark R Kilgore
Publikováno v:
American Journal of Clinical Pathology
Objectives CD200 expression has been well studied in hematopoietic malignancies; however, CD200 expression has not been well-characterized in neuroendocrine neoplasms. We examined CD200 expression in 391 neuroendocrine neoplasms from various anatomic
Autor:
Fatemeh Behnia, Serena Monti, Lorenzo Di Cesare Mannelli, Steven J. Kussick, Anna McLuen, Jason E. Love
Publikováno v:
Clinical Nuclear Medicine. 40:247-249
A 49-year-old woman with history of breast cancer presented with pain at the level of the left anterior proximal tibia. An x-ray of the tibia demonstrated a lytic cortical lesion that prompted a whole-body 99mTc-MDP bone scan. The bone scan revealed
Publikováno v:
Cytometry Part B: Clinical Cytometry. 84:286-290
Publikováno v:
Cytometry Part B: Clinical Cytometry. 84:291-308
Flow cytometry and other technologies of cell-based fluorescence assays are as a matter of good laboratory practice required to validate all assays, which when in clinical practice may pass through regulatory review processes using criteria often def
Autor:
Patricia L Kandalaft, Steven J. Kussick, Lynn C. Goldstein, Jesse C. Wiley, Chun Hing Tse, Harry C. Hwang, Allen M. Gown
Publikováno v:
Journal of Clinical Oncology. 29:4168-4174
Purpose The ratio of human epidermal growth factor receptor 2 (HER2) to CEP17 by fluorescent in situ hybridization (FISH) with the centromeric probe CEP17 is used to determine HER2 gene status in breast cancer. Increases in CEP17 copy number have bee
Autor:
Steven J. Kussick, Allen M. Gown, Christopher C Tse, Lynn C. Goldstein, Todd S Barry, Patricia M Kim, Patricia L Kandalaft
Publikováno v:
Modern Pathology. 21:1271-1277
The American Society of Clinical Oncologists and College of American Pathologists have recently released new guidelines for laboratory testing of HER2 status in breast cancer, which require high levels (95%) of concordance between immunohistochemistr